The COVID-19 pandemic in Iran has resulted in 7,627,863 confirmed cases of COVID-19 and 146,837 deaths.
Coronavirus patients at the Imam Khomeini Hospital in Tehran
A patient receiving treatment in a hospital in Tehran.
People in Shiraz wearing face masks next to a closed market.
Doctors at Milad Hospital in September 2020.
COVIran Barekat is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical Group. It is an inactivated virus-based vaccine. Iranian authoritie
COVID-19 pandemic in Iran
…Vaccine that have received emergency use authorization (EUA): COVIran Barekat: received EUA on 13 June 2021. Pasteurcovac (or Soberana 02): developed in collaboration with Cuba, received EUA in Iran on 29 June 2021…
A vial of COVIran Barakat
First production line, March 2021
COVIran Barekat -- Phases II and III of the clinical trials